CONTACT US: Contact info
|
Citation |
Plog BA, Dashnaw ML, Hitomi E, Peng W, Liao Y, Lou N, Deane R, Nedergaard M. J. Neurosci. 2015; 35(2): 518-526. |
|
Affiliation |
Center for Translational Neuromedicine, Department of Neurosurgery and Maiken_Nedergaard@URMC.Rochester.edu. |
|
Copyright |
(Copyright © 2015, Society for Neuroscience) |
|
DOI |
|
PMID |
25589747 |
|
Abstract |
The nonspecific and variable presentation of traumatic brain injury (TBI) has motivated an intense search for blood-based biomarkers that can objectively predict the severity of injury. However, it is not known how cytosolic proteins released from traumatized brain tissue reach the peripheral blood. Here we show in a murine TBI model that CSF movement through the recently characterized glymphatic pathway transports biomarkers to blood via the cervical lymphatics. Clinically relevant manipulation of glymphatic activity, including sleep deprivation and cisternotomy, suppressed or eliminated TBI-induced increases in serum S100β, GFAP, and neuron specific enolase. We conclude that routine TBI patient management may limit the clinical utility of blood-based biomarkers because their brain-to-blood transport depends on glymphatic activity. Language: en |